{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Managing Patients Who Are Immunocompromised During the COVID-19 Pandemic

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Identify strategies for immunocompromised individuals to prevent infection with SARS-CoV-2.
  2. Explain issues related to immunodeficiency.
  3. Identify a laboratory test that may indicate if a patient has COVID-19.
  4. Select the recommended timing of antiviral agents to treat a patient who has COVID-19.
  5. Select an approach to decrease the risk of depression from social isolation.

Learning Outcomes

Participants will demonstrate competency in clinical reasoning regarding strategies to prevent infection and promote quality of life in patients who are immunocompromised during the COVID-19 pandemic by achieving a minimum score of 70% on the outcomes-based posttest.
Price: $21.95


  • ANCC 2.0 CH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH
  • GA - BON 2.0 CH
  • NM - BON 2.0 CH
  • SC - BON 2.0 CH
  • WV - BOERN 2.0 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.

Test Code: N1222A
Published: Dec 2022
Expires: 9/5/2025
Sources: Nursing2023
Required Passing Score: 8/10 (80%)
Authors: Richard L. Pullen, JR., EdD, MSN, RN, CMSRN, CNE, CNE-cl, ANEF
Topics: COVID-19